Researchers at McGill University have developed a rapid way to engineer blood clots that stop severe bleeding and support ...
In 2021, the lab of chemical biologist and Nobel Laureate Carolyn Bertozzi, PhD, professor at Stanford University, characterized a new type of cell-surface protein, termed glycoRNAs, that form highly ...
Not all patients respond well to chimeric antigen receptor (CAR) T cell therapies, which reprogram a patient’s own immune cells to recognize and attack cancer. A way to optimize these treatments is to ...
Sapient, a leader in multi-omics data generation for biomarker discovery and clinical insight delivery, has announced the launch of its Tumor Protein Mapping Platform as a suite of mass ...
Dr. Scott Lowe, Chair of the Cancer Biology and Genetics Program and Scientific Director of the Marie-Josée and Henry R. Kravis Cancer Ecosystems Project, co-led a team that developed a new type of ...
Cell-surface RNAs, including glycoRNAs, have been described, yet their precise composition across primary cell types remains unresolved, in part due to technical challenges in preserving membrane ...
The identification of reliable biomarkers from peripheral blood is crucial for improving disease diagnosis and monitoring. Spectral flow cytometry has emerged as a powerful tool for high-dimensional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results